In its June 20, 2016 ruling in RJR Nabisco, Inc. v. European Community, the U.S. Supreme Court settled a long-running debate on the extraterritorial application of the Racketeering Influenced and Corrupt Organizations Act
On Wednesday, June 8, 2016, a bill was introduced in Congress that would, if passed, amend the Federal Food, Drug, and Cosmetic Act to require physicians and physicians’ offices to submit reports to FDA on hazards relating to medical devices.
On Thursday, June 16, the Supreme Court issued its opinion in Universal Health Services v. United States ex rel. Escobar, an opinion with important implications for companies seeking to assess and manage their legal risks under the False Claims Act.
On May 26, 2016, the US Court of Appeals for the Eleventh Circuit issued a decision in SEC v. Graham, curtailing the SEC’s ability to seek disgorgement of allegedly ill-gotten profits beyond five years from the time the claim first accrued.
The DOJ issued a Pilot Program1 that provides its latest answer to a critical question in FCPA practice: What benefits does a company receive for self-reporting potential FCPA violations?